Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Apr 3, 2020
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
PPTA considers that the SARS-CoV-2 outbreak is not a concern for the safety of plasma protein therapies manufactured by PPTA member companies. The assessment is shared by notable international and national public health bodies, including the WHO, the ECDC, and others.
All
PPTA statements
Apr 3, 2020
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
PPTA considers that the SARS-CoV-2 outbreak is not a concern for the safety of plasma protein therapies manufactured by PPTA member companies. The assessment is shared by notable international and national public health bodies, including the WHO, the ECDC, and others.
All
PPTA statements
Mar 26, 2020
PPTA Responds to The Guardian Article
An article published March 25 by Stefanie Dodt and Samuel Gilbert in The Guardian continues the authors’ intentional maligning of plasma donors along the U.S.-Mexico border and perpetuates a divisive misrepresentation of the reality of border life between the United States and Mexico.
All
PPTA statements
Mar 26, 2020
PPTA Responds to The Guardian Article
An article published March 25 by Stefanie Dodt and Samuel Gilbert in The Guardian continues the authors’ intentional maligning of plasma donors along the U.S.-Mexico border and perpetuates a divisive misrepresentation of the reality of border life between the United States and Mexico.
All
PPTA statements
Mar 16, 2020
Plasma-Derived Therapies Provide Significant Health Value Gain
New report analyses clinical, economic, and societal perspectives for patient access.
All
Press releases
Mar 16, 2020
Plasma-Derived Therapies Provide Significant Health Value Gain
New report analyses clinical, economic, and societal perspectives for patient access.
All
Press releases
Mar 16, 2020
A Note to U.S. Plasma Donors on the Spread of Coronavirus
At this time of global concern regarding spread of the novel coronavirus, PPTA wants to thank the millions of committed plasma donors who make lifesaving medicines for rare disease patients a reality and to remind them that donor safety continues to be a top priority for PPTA and its member companies.
All
PPTA statements
Mar 16, 2020
A Note to U.S. Plasma Donors on the Spread of Coronavirus
At this time of global concern regarding spread of the novel coronavirus, PPTA wants to thank the millions of committed plasma donors who make lifesaving medicines for rare disease patients a reality and to remind them that donor safety continues to be a top priority for PPTA and its member companies.
All
PPTA statements
Aucun résultat n'a été trouvé